Free androgen index and Irisin in polycystic ovary syndrome

J Endocrinol Invest. 2016 May;39(5):549-56. doi: 10.1007/s40618-015-0403-7. Epub 2015 Nov 19.

Abstract

Purpose: PCOS is associated with hyperandrogenism and insulin resistance (IR). Recent studies have shown that circulating Irisin levels increase in PCOS women. However, no report has demonstrated a relationship between Irisin and hyperandrogenism in PCOS women. The purpose of the study was to compare interrelationship between Irisin or androgen excess with IR in PCOS and normal subjects.

Methods: 166 PCOS and 103 control women were prospectively studied. Euglycemic- hyperinsulinemic clamps were preformed to assess their insulin sensitivity, which was expressed as M value. Circulating Irisin was determined by ELISA kit. Circulating androgens were measured using ultrasensitive assays.

Results: PCOS women with high FAI had significantly higher BMI, FAT%, TC, DHEA-S and HOMA-IR, and significantly lower levels of M values and SHBG than PCOS women with low FAI or the controls. Pearson correlations showed that in the entire population, FAI correlated positively with BMI, WHR, FAT%, blood pressure, TG, DHEA-S, LH/FSH, AUCinsulin, HOMA-IR and Irisin, and negatively with M values. In multiple stepwise regression analysis, only FAT%, DHEA-S and LH/FSH were independent related factors with FAI.

Conclusion: The elevated Irisin levels in PCOS women were associated with androgen excess. Circulating Irisin is a primary predictor of hyperandrogenism, MetS and IR in PCOS women.

Keywords: Free androgen index; Insulin resistance; Irisin; Polycystic ovary syndrome; Sex hormone.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Androgens / blood*
  • Case-Control Studies
  • Female
  • Fibronectins / blood*
  • Humans
  • Hyperandrogenism / blood*
  • Hyperandrogenism / complications
  • Hyperandrogenism / pathology
  • Insulin Resistance*
  • Polycystic Ovary Syndrome / blood*
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / pathology
  • Prognosis
  • Prospective Studies
  • Young Adult

Substances

  • Androgens
  • FNDC5 protein, human
  • Fibronectins